Post by
JMark80 on Jul 18, 2018 12:32pm
Another questionable Avtar Dhillon company
~$50 mm cap fully diluted for a capital constrained company that has no products in clinical development. They're also under investigation by the SEC and have employed questionable promotion tactics, both as Vitality and Stevia First. They have patents, but there are many ways to increase solubility, not just glycosylation.
Comment by
JMark80 on Jan 22, 2019 11:23pm
Called this BS company out at $1.80. Suspended by the SEC and now trading on the grey market! Yikes! That's all folks!
Comment by
Stockqueen77 on Jul 14, 2021 8:19pm
how is this stock still active...